Jason Stadanlick

2.4k total citations
32 papers, 1.6k citations indexed

About

Jason Stadanlick is a scholar working on Immunology, Oncology and Cancer Research. According to data from OpenAlex, Jason Stadanlick has authored 32 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Immunology, 9 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Jason Stadanlick's work include Immune Cell Function and Interaction (16 papers), T-cell and B-cell Immunology (9 papers) and CAR-T cell therapy research (4 papers). Jason Stadanlick is often cited by papers focused on Immune Cell Function and Interaction (16 papers), T-cell and B-cell Immunology (9 papers) and CAR-T cell therapy research (4 papers). Jason Stadanlick collaborates with scholars based in United States, Australia and India. Jason Stadanlick's co-authors include Michael P. Cancro, Fusao Ikeda, Kazushi Sugimoto, Kyong‐Mi Chang, Harvey J. Alter, Frederick A. Nunes, Laura S. Treml, Juli P. Miller, Sunil Singhal and Yi Hao and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Nature Immunology.

In The Last Decade

Jason Stadanlick

31 papers receiving 1.6k citations

Peers

Jason Stadanlick
Marcella Visentini Italy
Diana F. Hausman United States
Patrick P.C. Boor Netherlands
Patrizia Leone Italy
Shanta Mancham Netherlands
Marie‐Christine Jacob France
Csaba Bödör Hungary
Gigliola Reato Italy
Michael Cruise United States
Lise Boussemart France
Marcella Visentini Italy
Jason Stadanlick
Citations per year, relative to Jason Stadanlick Jason Stadanlick (= 1×) peers Marcella Visentini

Countries citing papers authored by Jason Stadanlick

Since Specialization
Citations

This map shows the geographic impact of Jason Stadanlick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason Stadanlick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason Stadanlick more than expected).

Fields of papers citing papers by Jason Stadanlick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason Stadanlick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason Stadanlick. The network helps show where Jason Stadanlick may publish in the future.

Co-authorship network of co-authors of Jason Stadanlick

This figure shows the co-authorship network connecting the top 25 collaborators of Jason Stadanlick. A scholar is included among the top collaborators of Jason Stadanlick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason Stadanlick. Jason Stadanlick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mozaffar, Tahseen, Jason Stadanlick, Alexandra G. Ellis, et al.. (2024). Case study of CD19 CAR T therapy in a subject with immune-mediate necrotizing myopathy treated in the RESET-Myositis phase I/II trial. Molecular Therapy. 32(11). 3821–3828. 17 indexed citations
2.
Singhal, Sunil, Abhishek S. Rao, Jason Stadanlick, et al.. (2024). Human Tumor–Associated Macrophages and Neutrophils Regulate Antitumor Antibody Efficacy through Lethal and Sublethal Trogocytosis. Cancer Research. 84(7). 1029–1047. 16 indexed citations
3.
Predina, Jarrod D., Andrew R. Haas, Marina C. Martinez, et al.. (2020). Neoadjuvant Gene-Mediated Cytotoxic Immunotherapy for Non-Small-Cell Lung Cancer: Safety and Immunologic Activity. Molecular Therapy. 29(2). 658–670. 12 indexed citations
4.
Klampatsa, Astero, Shaun O’Brien, Jeffrey C. Thompson, et al.. (2019). Phenotypic and functional analysis of malignant mesothelioma tumor-infiltrating lymphocytes. OncoImmunology. 8(9). e1638211–e1638211. 34 indexed citations
5.
Singhal, Sunil, Jason Stadanlick, Abhishek Rao, et al.. (2019). Human tumor-associated monocytes/macrophages and their regulation of T cell responses in early-stage lung cancer. Science Translational Medicine. 11(479). 183 indexed citations
6.
Corbett, Christopher, Jarrod D. Predina, Andrew D. Newton, et al.. (2019). Comparison of a Short Versus Long Stokes Shift Near-Infrared Dye During Intraoperative Molecular Imaging. Molecular Imaging and Biology. 22(1). 144–155. 5 indexed citations
7.
Predina, Jarrod D., Andrew D. Newton, Ashley Dunbar, et al.. (2017). Identification of a Folate Receptor-Targeted Near-Infrared Molecular Contrast Agent to Localize Pulmonary Adenocarcinomas. Molecular Therapy. 26(2). 390–403. 53 indexed citations
8.
Akimova, Tatiana, Dmitri Negorev, Sunil Singhal, et al.. (2017). Human lung tumor FOXP+ Tregs upregulate four “Treg-locking” transcription factors. JCI Insight. 2(16). 47 indexed citations
9.
Rao, Shuyun, Kathy Q. Cai, Jason Stadanlick, et al.. (2016). Ribosomal Protein Rpl22 Controls the Dissemination of T-cell Lymphoma. Cancer Research. 76(11). 3387–3396. 28 indexed citations
10.
Lee, Sang-Yun, Jason Stadanlick, Dietmar J. Kappes, & David L. Wiest. (2010). Towards a molecular understanding of the differential signals regulating αβ/γδ T lineage choice. Seminars in Immunology. 22(4). 237–246. 32 indexed citations
11.
Stadanlick, Jason & Michael P. Cancro. (2008). BAFF and the plasticity of peripheral B cell tolerance. Current Opinion in Immunology. 20(2). 158–161. 63 indexed citations
12.
Treml, Jack, Yi Hao, Jason Stadanlick, & Michael P. Cancro. (2008). The BLyS Family: Toward a Molecular Understanding of B Cell Homeostasis. Cell Biochemistry and Biophysics. 53(1). 1–16. 83 indexed citations
13.
Stadanlick, Jason, Mary Kaileh, Fredrick G. Karnell, et al.. (2008). Tonic B cell antigen receptor signals supply an NF-κB substrate for prosurvival BLyS signaling. Nature Immunology. 9(12). 1379–1387. 161 indexed citations
14.
Treml, Laura S., Gianluca Carlesso, Kristen L. Hoek, et al.. (2007). TLR Stimulation Modifies BLyS Receptor Expression in Follicular and Marginal Zone B Cells. The Journal of Immunology. 178(12). 7531–7539. 131 indexed citations
15.
Miller, Juli P., Jason Stadanlick, & Michael P. Cancro. (2006). Space, Selection, and Surveillance: Setting Boundaries with BLyS. The Journal of Immunology. 176(11). 6405–6410. 77 indexed citations
16.
Kaplan, David E., Kazushi Sugimoto, Fusao Ikeda, et al.. (2005). T‐cell response relative to genotype and ethnicity during antiviral therapy for chronic hepatitis C†. Hepatology. 41(6). 1365–1375. 42 indexed citations
17.
Crowley, Jenni E., Laura S. Treml, Jason Stadanlick, Erica L. Carpenter, & Michael P. Cancro. (2005). Homeostatic niche specification among naïve and activated B cells: A growing role for the BLyS family of receptors and ligands. Seminars in Immunology. 17(3). 193–199. 43 indexed citations
18.
Sugimoto, Kazushi, Fusao Ikeda, Jason Stadanlick, et al.. (2003). Suppression of Hcv–Specific T Cells Without Differential Hierarchy Demonstrated Ex Vivo In Persistent Hcv Infection. Hepatology. 38(6). 1437–1448. 290 indexed citations
19.
Sugimoto, Kazushi, Jason Stadanlick, Fusao Ikeda, et al.. (2003). Influence of Ethnicity in the Outcome of Hepatitis C Virus Infection and Cellular Immune Response. Hepatology. 37(3). 590–599. 95 indexed citations
20.
Mast, Alan E., Jason Stadanlick, Jaron Lockett, & Dennis J. Dietzen. (1999). Solvent/Detergent-Treated Plasma Has Decreased Antitrypsin Activity and Absent Antiplasmin Activity. Blood. 94(11). 3922–3927. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marcella Visentini Breakdown of academic impact, for papers by Diana F. Hausman Breakdown of academic impact, for papers by Patrick P.C. Boor Breakdown of academic impact, for papers by Patrizia Leone Breakdown of academic impact, for papers by Shanta Mancham Breakdown of academic impact, for papers by Marie‐Christine Jacob Breakdown of academic impact, for papers by Csaba Bödör Breakdown of academic impact, for papers by Gigliola Reato Breakdown of academic impact, for papers by Michael Cruise Breakdown of academic impact, for papers by Lise Boussemart
Rankless by CCL
2026